慢性阻塞性肺部疾病的诊断和门诊治疗:一篇评论
Craig M Riley1, Frank C Sciurba1
1Division of Pulmonary, Department of Medicine, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
JAMA
|February 27, 2019
概括
慢性阻塞性肺病 (COPD) 的治疗正在发展. 主要治疗方法包括长效支气管扩展剂,吸入性皮质类固醇,肺复原治疗和氧气治疗,改善患者的治疗结果.
科学领域:
- 肺部医学
- 内部医学
背景情况:
- 慢性阻塞性肺病 (COPD) 影响了3000万美国成年人,是导致死亡的主要原因,
- 主要医疗保健医生诊断和管理COPD,因为其可变的临床特征和治疗反应而面临挑战.
- 在COPD诊断和治疗方面取得的快速进展需要最新的知识来提供最佳的患者护理.
研究的目的:
- 审查目前对COPD诊断和治疗的认识和最新进展.
- 强调基于证据的治疗策略对于改善患者的结果的重要性.
主要方法:
- 诊断依赖于螺旋测量来评估不完全可逆的呼气流量限制.
- 治疗是根据疾病的严重程度,症状 (喘息,咳,吐) 和恶化的频率进行的.
- 主要干预措施包括戒烟,接种疫苗,长效支气管扩展剂,吸入的皮质类固醇,肺部康复和补充氧气.
主要成果:
- 长效支气管扩展剂,吸入性皮质类固醇和肺部康复疗法有效减少症状,改善功能,减少恶化.
- 补充氧气治疗静止低氧症 (Spo2 < 89%) 已被证明可以改善存活率.
- 肺部康复治疗虽然未得到充分利用,
结论:
- 慢性肺炎是一种复杂的疾病,
- 适当使用支气管扩展剂,吸入皮质类固醇,肺部康复和氧气治疗显著改善了生命质量和存活率.
- 针对特定患者的高级疗法可用,这强调了持续临床更新的必要性.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
COPD: Management Using Bronchodilators and Corticosteroids
705
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
705
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K


